We surveyed the stocks most commonly held by some of the best boutique mutual funds to see which small- and mid-cap names potentially merit greater attention. Read More
The following search results are from Investing Daily's public research only. Please Log In to search your premium services.
Results
While Vietnam has enjoyed a period of prosperity and rapid growth spanning nearly three decades, the country has hit a bump in the road as it deals with a banking scandal. Read More
The company’s aggressive overseas expansion and new product launches are starting to pay off. Read More
Exchange traded funds (ETFs) are a perfect tool for asset allocation. But be careful; ETFs are often labeled similarly but can be very different in terms of holdings, fees, and liquidity. Read More
Home builder stocks registered big gains following the announcement of QE3 by the Federal Reserve. However, there’s little reason to think that the Fed’s latest stimulus will provide a long-term lift for this sector. Read More
One of the most important and fastest-growing transactions in personal finance is growing under the radar of most of the financial media and other observers. It and the follow-on transactions are critical to the financial lives of most Americans. Yet, people receive little guidance on the transactions and, as a result, frequently have thousands of dollars siphoned by taxes. Read More
Hammerfest, Norway claims to be the northernmost city in the world. Although you might quibble that an area with population of only 10,000 isn’t much of a city, a booming energy industry could swell the population in coming years. Read More
The Federal Reserve's QE Infinity decision to buy $40 billion per month in bonds promises stagflation. This presents some interesting investment themes for the future. Read More
Even the best investments in this highly volatile business aren’t for the faint of heart. Here’s why. Read More
The days when pharmaceutical companies ignored rare diseases because the market was too small are gone. Treating rare diseases with orphan drugs is big business. Read More
Stock Talk Results
No Comments Found